Though relatively rare, mutations in the mitochondrial genome (mtDNA) can cause some serious, progressive and often fatal diseases. Technical advances now permit replacement of these mutated mitochondria in the oocyte of the potential mother. A recent editorial in the New England Journal of Medicine (March 24, 2016) discusses the medical, technical, economic and ethical issues surrounding mitochondrial replacement.